These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38202282)

  • 21. Recovery from Exercise in Persons with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Moore GE; Keller BA; Stevens J; Mao X; Stevens SR; Chia JK; Levine SM; Franconi CJ; Hanson MR
    Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984572
    [No Abstract]   [Full Text] [Related]  

  • 22. Natural killer cytotoxicity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a multi-site clinical assessment of ME/CFS (MCAM) sub-study.
    Querec TD; Lin JS; Chen Y; Helton B; Kogelnik AM; Klimas NG; Peterson DL; Bateman L; Lapp C; Podell RN; Natelson BH; Unger ER;
    J Transl Med; 2023 Apr; 21(1):242. PubMed ID: 37013608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Post-COVID syndrome with fatigue and exercise intolerance: myalgic encephalomyelitis/chronic fatigue syndrome].
    Renz-Polster H; Scheibenbogen C
    Inn Med (Heidelb); 2022 Aug; 63(8):830-839. PubMed ID: 35925074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
    Maes M; Twisk FN; Ringel K
    Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Nagy-Szakal D; Williams BL; Mishra N; Che X; Lee B; Bateman L; Klimas NG; Komaroff AL; Levine S; Montoya JG; Peterson DL; Ramanan D; Jain K; Eddy ML; Hornig M; Lipkin WI
    Microbiome; 2017 Apr; 5(1):44. PubMed ID: 28441964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory and oxidative and nitrosative stress cascades as new drug targets in myalgic encephalomyelitis and chronic fatigue syndrome.
    Maes M
    Mod Trends Pharmacopsychiatry; 2013; 28():162-74. PubMed ID: 25224898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Could the kynurenine pathway be the key missing piece of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) complex puzzle?
    Kavyani B; Lidbury BA; Schloeffel R; Fisher PR; Missailidis D; Annesley SJ; Dehhaghi M; Heng B; Guillemin GJ
    Cell Mol Life Sci; 2022 Jul; 79(8):412. PubMed ID: 35821534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shadow Burden of Undiagnosed Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) on Society: Retrospective and Prospective-In Light of COVID-19.
    Araja D; Berkis U; Lunga A; Murovska M
    J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Post-COVID Syndrome: A Common Neuroimmune Ground?
    Ryabkova VA; Gavrilova NY; Fedotkina TV; Churilov LP; Shoenfeld Y
    Diagnostics (Basel); 2022 Dec; 13(1):. PubMed ID: 36611357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Cliff JM; King EC; Lee JS; Sepúlveda N; Wolf AS; Kingdon C; Bowman E; Dockrell HM; Nacul L; Lacerda E; Riley EM
    Front Immunol; 2019; 10():796. PubMed ID: 31057538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigating Antibody Reactivity to the Intestinal Microbiome in Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Feasibility Study.
    Seton KA; Defernez M; Telatin A; Tiwari SK; Savva GM; Hayhoe A; Noble A; de Carvalho-KoK ALS; James SA; Bansal A; Wileman T; Carding SR
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term symptom severity and clinical biomarkers in post-COVID-19/chronic fatigue syndrome: results from a prospective observational cohort.
    Legler F; Meyer-Arndt L; Mödl L; Kedor C; Freitag H; Stein E; Hoppmann U; Rust R; Wittke K; Siebert N; Behrens J; Thiel A; Konietschke F; Paul F; Scheibenbogen C; Bellmann-Strobl J
    EClinicalMedicine; 2023 Sep; 63():102146. PubMed ID: 37662515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS).
    König RS; Albrich WC; Kahlert CR; Bahr LS; Löber U; Vernazza P; Scheibenbogen C; Forslund SK
    Front Immunol; 2021; 12():628741. PubMed ID: 35046929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unravelling myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Gender-specific changes in the microRNA expression profiling in ME/CFS.
    Cheema AK; Sarria L; Bekheit M; Collado F; Almenar-Pérez E; Martín-Martínez E; Alegre J; Castro-Marrero J; Fletcher MA; Klimas NG; Oltra E; Nathanson L
    J Cell Mol Med; 2020 May; 24(10):5865-5877. PubMed ID: 32291908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of Post-Exertional Malaise (PEM) in Patients with Myalgic Encephalomyelitis (ME) and Chronic Fatigue Syndrome (CFS): A Patient-Driven Survey.
    Holtzman CS; Bhatia S; Cotler J; Jason LA
    Diagnostics (Basel); 2019 Mar; 9(1):. PubMed ID: 30832336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating levels of GDF15 in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Melvin A; Lacerda E; Dockrell HM; O'Rahilly S; Nacul L
    J Transl Med; 2019 Dec; 17(1):409. PubMed ID: 31801546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiopulmonary Exercise Test Methodology for Assessing Exertion Intolerance in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Stevens S; Snell C; Stevens J; Keller B; VanNess JM
    Front Pediatr; 2018; 6():242. PubMed ID: 30234078
    [No Abstract]   [Full Text] [Related]  

  • 38. A scoping review of 'Pacing' for management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): lessons learned for the long COVID pandemic.
    Sanal-Hayes NEM; Mclaughlin M; Hayes LD; Mair JL; Ormerod J; Carless D; Hilliard N; Meach R; Ingram J; Sculthorpe NF
    J Transl Med; 2023 Oct; 21(1):720. PubMed ID: 37838675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review of case definitions for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Lim EJ; Son CG
    J Transl Med; 2020 Jul; 18(1):289. PubMed ID: 32727489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The underlying sex differences in neuroendocrine adaptations relevant to Myalgic Encephalomyelitis Chronic Fatigue Syndrome.
    Thomas N; Gurvich C; Huang K; Gooley PR; Armstrong CW
    Front Neuroendocrinol; 2022 Jul; 66():100995. PubMed ID: 35421511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.